APP and Alzheimer disease: In this study, the secretion of APP amyloid degradation pathway products Aβ1-42 increased after IL-17A was added to APP-transfected HT22 cells, which indicates that IL-17A can promote the production of Aβ peptides and exacerbate the process of AD by promoting the APP amyloid pathway.